Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):412–418. doi: 10.1016/j.ijrobp.2013.11.002

Fig. 5.

Fig. 5

(A) Average percentage change in perfusion and Fp for the positive (n=4) and negative (n= 5) responding tumors 1-week post-DC101 treatment are compared to corresponding baseline values. (B) Average relative growth in the positive and negative responding tumors is compared to 5 and 7 Gy RT groups. (C) Represents the portion inside the dashed line rectangular in Fig. 5B, which highlights the reduced variance and statistical significance in the early tumor growth delay response. (* P<0.05; ** P<0.01; error bar:±SD)